Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000840940 | SCV000982889 | likely benign | not provided | 2020-02-06 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV001171177 | SCV001333869 | likely benign | Cardiomyopathy | 2018-03-27 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001497474 | SCV001702203 | likely benign | Hypertrophic cardiomyopathy 14 | 2020-10-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002336740 | SCV002638215 | likely benign | Cardiovascular phenotype | 2019-03-16 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV004735826 | SCV005363840 | likely benign | MYH6-related disorder | 2019-08-28 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |